KAIN_HUMAN - dbPTM
KAIN_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID KAIN_HUMAN
UniProt AC P29622
Protein Name Kallistatin
Gene Name SERPINA4
Organism Homo sapiens (Human).
Sequence Length 427
Subcellular Localization Secreted.
Protein Description Inhibits human amidolytic and kininogenase activities of tissue kallikrein. Inhibition is achieved by formation of an equimolar, heat- and SDS-stable complex between the inhibitor and the enzyme, and generation of a small C-terminal fragment of the inhibitor due to cleavage at the reactive site by tissue kallikrein..
Protein Sequence MHLIDYLLLLLVGLLALSHGQLHVEHDGESCSNSSHQQILETGEGSPSLKIAPANADFAFRFYYLIASETPGKNIFFSPLSISAAYAMLSLGACSHSRSQILEGLGFNLTELSESDVHRGFQHLLHTLNLPGHGLETRVGSALFLSHNLKFLAKFLNDTMAVYEAKLFHTNFYDTVGTIQLINDHVKKETRGKIVDLVSELKKDVLMVLVNYIYFKALWEKPFISSRTTPKDFYVDENTTVRVPMMLQDQEHHWYLHDRYLPCSVLRMDYKGDATVFFILPNQGKMREIEEVLTPEMLMRWNNLLRKRNFYKKLELHLPKFSISGSYVLDQILPRLGFTDLFSKWADLSGITKQQKLEASKSFHKATLDVDEAGTEAAAATSFAIKFFSAQTNRHILRFNRPFLVVIFSTSTQSVLFLGKVVDPTKP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
30PhosphorylationHVEHDGESCSNSSHQ
EECCCCCCCCCCCCH
28.5127130503
32PhosphorylationEHDGESCSNSSHQQI
CCCCCCCCCCCCHHH
49.3727130503
33N-linked_GlycosylationHDGESCSNSSHQQIL
CCCCCCCCCCCHHHH
52.43UniProtKB CARBOHYD
34PhosphorylationDGESCSNSSHQQILE
CCCCCCCCCCHHHHH
16.9527130503
35PhosphorylationGESCSNSSHQQILET
CCCCCCCCCHHHHHC
29.5727130503
63PhosphorylationADFAFRFYYLIASET
CCEEEEEHHHHHCCC
7.97-
64PhosphorylationDFAFRFYYLIASETP
CEEEEEHHHHHCCCC
6.74-
68PhosphorylationRFYYLIASETPGKNI
EEHHHHHCCCCCCCC
34.70-
108N-linked_GlycosylationILEGLGFNLTELSES
HHHHCCCCCCCCCHH
44.2316335952
145N-linked_GlycosylationRVGSALFLSHNLKFL
CCCHHHHHHHCHHHH
5.4616335952
145N-linked_GlycosylationRVGSALFLSHNLKFL
CCCHHHHHHHCHHHH
5.4616335952
157N-linked_GlycosylationKFLAKFLNDTMAVYE
HHHHHHHHHHHHHHH
45.9312754519
194N-linked_GlycosylationKKETRGKIVDLVSEL
CHHHHCCHHHHHHHH
3.0312754519
194N-linked_GlycosylationKKETRGKIVDLVSEL
CHHHHCCHHHHHHHH
3.0312754519
225PhosphorylationLWEKPFISSRTTPKD
HHCCCCCCCCCCCCC
17.7229083192
226PhosphorylationWEKPFISSRTTPKDF
HCCCCCCCCCCCCCE
28.9129083192
228PhosphorylationKPFISSRTTPKDFYV
CCCCCCCCCCCCEEE
49.7729083192
229PhosphorylationPFISSRTTPKDFYVD
CCCCCCCCCCCEEEC
27.5129083192
238N-linked_GlycosylationKDFYVDENTTVRVPM
CCEEECCCCEEEEEE
36.2619139490
275N-linked_GlycosylationMDYKGDATVFFILPN
EEECCCEEEEEECCC
23.6816335952
275N-linked_GlycosylationMDYKGDATVFFILPN
EEECCCEEEEEECCC
23.6816335952
326PhosphorylationPKFSISGSYVLDQIL
CCCEEECHHHHHHHH
12.79-
343PhosphorylationLGFTDLFSKWADLSG
CCCHHHHHHHHCCCC
34.2924719451
360PhosphorylationKQQKLEASKSFHKAT
HHHHHHHCHHHHHHE
21.3226437602

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of KAIN_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of KAIN_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of KAIN_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FKB14_HUMANFKBP14physical
26186194
FDFT_HUMANFDFT1physical
26186194
FKB14_HUMANFKBP14physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of KAIN_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-108; ASN-157 AND ASN-238,AND MASS SPECTROMETRY.
"Identification and quantification of N-linked glycoproteins usinghydrazide chemistry, stable isotope labeling and mass spectrometry.";
Zhang H., Li X.-J., Martin D.B., Aebersold R.;
Nat. Biotechnol. 21:660-666(2003).
Cited for: GLYCOSYLATION AT ASN-157.

TOP